After the Texas Medical Center Venture Fund invested in CrossBridge Bio, TMC President and CEO William McKeon joined the ...

Coya Therapeutics has announced a change in leadership with Dr. Arun Swaminathan stepping in as CEO, following Dr. Howard Berman’s resignation. Swaminathan’s new role comes with a base salary ...

Seattle-based biotech Shape Therapeutics has tapped David Huss, its chief scientific officer, as interim CEO after Francois Vigneault stepped down from the role earlier this month. Vigneault ...

Dr. Steven M. Altschuler, who served 15 years as CEO of The Children’s Hospital of Philadelphia and is the co-founder of ...

Johnson joins Kesmalea after serving as Chief Executive Officer of Adrestia Therapeutics, a leader in the field of synthetic rescue that was acquired by global biopharmaceutical company Insmed ...

Tiago Reis Marques, M.D., Ph.D. is the Chief Executive Officer of Pasithea Therapeutics Corp. Dr. Marques is a fellow at Imperial College London and a lecturer at the Institute of Psychiatry ...

HOUSTON, Nov. 5, 2024 /PRNewswire/ -- Celltex Therapeutics Corporation, a biotechnology company that specializes in the manufacturing and cryopreservation of Mesenchymal Stem Cells (MSC) for ...

The Virtual Investor CEO Connect featuring Outlook Therapeutics is now available here. About Outlook Therapeutics, Inc. Outlook Therapeutics is a biopharmaceutical company focused on the ...

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ ... announces that Chairman and CEO Howard Berman, Ph.D. has been recognized as a PharmaVoice 100 winner in the category of Biotech ...

CNX Therapeutics Limited (“CNX Therapeutics”), a speciality pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines, today announced that CEO Guy ...

In a recent move, David Alan Campbell, the President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), has sold a substantial number of shares in the company. On September 27, 2024, Campbell parted ...